Scott Mulhauser/Erin Shields (Baucus) (202) 224-4515
Jill Gerber (Grassley) (202) 224-4515
Senators Call on Insurance Company to Honor Medicare Drug Benefit Claims
WASHINGTON – Senators Chuck Grassley and Max Baucus, Ranking Member and Chairman of the Senate Committee on Finance, are seeking more information on millions of dollars in unpaid Medicare Part D claims submitted to the Fox Insurance Company.
The company was terminated from participation in the Medicare prescription drug program on March 9, but not before it received more than $30,550,000 in February and more than $33,380,000 in March to provide Medicare Part D coverage to Fox Insurance Company enrollees.
The senators are seeking detailed information on how much of the more than $60 million in tax dollars the Fox Insurance Company is still holding and urging the insurer to pay all appropriately filed but outstanding pharmacy claims immediately.
Grassley and Baucus co-authored the legislation that created the Medicare Part D prescription drug benefit in 2003, and together continue to conduct oversight of the program on behalf of seniors.
The text of their letter follows here.
June 30, 2010
Mr. Kary Shankar
Chief Executive Officer
Fox Insurance Company
40 West 25th Street – 6th Floor
New York, NY 10010
Dear Mr. Shankar,
On March 9, 2010, we were notified by staff of the Centers for Medicare and Medicaid Services (CMS) that Fox Insurance Company’s (Fox/Company) Prescription Drug Plan (PDP) contract would be terminated for jeopardizing the health and safety of 123,000 Medicare beneficiaries who were Fox enrollees. As Chairman and Ranking Member of the U.S. Senate Committee on Finance (Committee) with jurisdiction over Medicare we have a responsibility to protect this program and its more than 41 million beneficiaries and ensure that taxpayer funds are used appropriately.
We have learned from CMS that, despite receiving payments from CMS totaling $30,550,000 for the month of February 2010 and over $33,380,000 for the month of March 2010, Fox has not paid some pharmacy claims for the period leading up to the March 9, 2010 termination of the contract by CMS. We find it particularly troubling that Fox is arguing in district court to have its contract reinstated while, according to CMS, the Company continues to ignore its original fiduciary obligations for the period when the contract was in force. According to CMS, failure to pay these claims is in direct violation of the original contract and prompt-pay requirements. CMS reiterated this to Fox recently in a May 17, 2010, letter, yet it is our understanding that Fox has still failed to pay those pharmacies having outstanding claims, despite the fact that Fox received funds from Medicare for the regular management of the drug benefit and payment of enrollee claims.
Accordingly, we ask that you provide us with the following information by July 9, 2010:
- Medicare paid Fox more than $66 million to provide prescription drug benefits for February and March. How much of this amount was being held by Fox Insurance Company as of June 1, 2010, and why?
- How many claims for services provided prior to the March 9th termination of your contract with Medicare have been received but remain unpaid as of the date of this letter?
- Please provide details, including specific dates, on whether or not Fox intends to pay any and all appropriately filed outstanding pharmacy claims.
- Please provide any other documents that you believe are relevant to any appropriately filed, unpaid claims.
In cooperating with the Committee’s review, no documents, records, data or information related to these matters shall be destroyed, modified, removed or otherwise made inaccessible to the Committee.
Thank you for your immediate attention to this important matter.
Chairman of the Committee on Finance
Charles E. Grassley
Ranking Member of the Committee on Finance
Next Article Previous Article
- Finance Committee Advances Treasury Nominee to Full Senate
- Grassley op-ed: Don’t Exploit Pandemic to Enact Liberal Laundry List
- Grassley at Hearing to Consider the Anticipated Nomination of the Honorable Janet L. Yellen to be Secretary of the Treasury
- Grassley, Wyden Release Insulin Investigation, Uncovering Business Practices Between Drug Companies and PBMs That Keep Prices High
- Grassley, Ernst’s Bill to Provide Tax Relief to Iowans Impacted by the Derecho Signed into Law